The role of the general practitioner in the diagnosis and treatment of benign prostatic hyperplasia (BPH)
Janknegt, R.A.; Roehrborn, C.G.
Progress in Clinical and Biological Research 386: 313-329
1994
ISSN/ISBN: 0361-7742 PMID: 7528400 Document Number: 434623
Document emailed within 1 workday
Related Documents
Eri, L.M.; Wahlqvist, R.; Tveter, K.J. 1996: Diagnosis and treatment of benign prostatic hyperplasia in general practice. Norwegian Medical Society Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 116(27): 3240-3244Schnur, S.; Keuler, F.U. 1996: Benign prostatic hyperplasia: diagnosis in general practice Fortschritte der Medizin 114(31): 412-415
Schlatmann, T.J. 1992: Benign prostatic hyperplasia; recommendations for diagnosis and treatment in 1992 Nederlands Tijdschrift Voor Geneeskunde 136(49): 2414-2417
Hiraoka, Y.; Sa, I. 2002: Biochemical diagnosis of benign prostatic hyperplasia (including differential diagnosis with prostatic carcinoma) Nihon Rinsho. Japanese Journal of Clinical Medicine 60(Suppl 11): 342-345
Granados Loarca, E.A. 1999: Medical treatment of benign prostatic hyperplasia. The efficacy of finasteride depends on prostatic volume Archivos Espanoles de Urologia 52(3): 201-208
Talseth, T.; Hedlund, H. 1997: Benign prostatic hyperplasia. Shared care between urologists and general practitioners Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 117(3): 389-393
Jonas, U.; Melchior, H.; Rübben, H. 1998: Recommendations for billing alternative therapy of benign prostatic hyperplasia. Laser therapy of benign prostatic hyperplasia Der Urologe. Ausg. a 37(1): 110-111
Lukacs, B.; Grange, J.C.; Comet, D.; Mc Carthy, C. 1999: Prospective follow-up of 3,228 patients suffering from clinical benign prostatic hyperplasia (BPH) treated for 3 years wi alfuzosin in general practice. BPH Group in General Practice Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 9(2): 271-280
Bogdanowicz, J.F.; Bentvelsen, F.M.; Oosterom, R.; Schroeder, F.H. 1991: Evaluation of prostate-specific antigen and prostatic acid phosphatase in untreated prostatic carcinoma and benign prostatic hyperplasia Scandinavian Journal of Urology and Nephrology. Supplementum 138: 97-103
McConnell, J.D. 1995: Benign prostatic hyperplasia. Hormonal treatment Urologic Clinics of North America 22(2): 387-400
Gorilovskiĭ, L.M. 1995: Permixon in the treatment of benign prostatic hyperplasia Terapevticheskii Arkhiv 67(8): 62-64
Kumanov, H.; Mladenov, D.; Nikolov, S.; Penkov, R.; Stratev, S.; Kotzev, R.; Petkova, L.; Ganev, T.; Uzunov, A.; Uzunov, N. 1998: Treatment of benign prostatic hyperplasia with tamsulosin Khirurgiia 53(6): 38-41
Ekman, P.; Andersen, J.T.; Wolf, H. 1996: Finasteride in the treatment of benign prostatic hyperplasia Acta Urologica Belgica 64(1): IX-XII
Roth, A. 1981: The role of the general practitioner and the family in the initial diagnosis and treatment of the squinting child Therapeutische Umschau. Revue Therapeutique 38(3): 228-234
Chepurov, A.K. 1999: Holmium laser treatment of benign prostatic hyperplasia Urologiia 4: 39-41
Lepor, H. 1995: Alpha blockade for the treatment of benign prostatic hyperplasia Urologic Clinics of North America 22(2): 375-386
Ustinov, D.V.; Kholtobin, D.P.; Kul'chavenia, E.V.; Aĭzikovich, B.I. 2013: The use of laser vaporization for the treatment of benign prostatic hyperplasia Urologiia 4: 74
Moon, L.; Pfettscher, S. 1995: Hytrin treatment of hypertension and benign prostatic hyperplasia Anna Journal 22(3): 335-336
Noda, Y.; Ujike, T.; Oka, D.; Takada, S.; Fujimoto, N.; Koide, T. 2003: Urethral stent (Memotherm) for the treatment of benign prostatic hyperplasia Hinyokika Kiyo. Acta Urologica Japonica 49(11): 645-647
Fu, W-jun.; Hong, B-fa.; Yang, Y.; Cai, W.; Gao, J-ping.; Wang, C-yang.; Wang, X-xiong. 2005: Photoselective vaporization of the prostate in the treatment of benign prostatic hyperplasia Chinese Medical Journal 118(19): 1610-1614